Grants and Contributions:
Title:
MNC Collab - IEVSSP - IAVI Elarex VSV Stability Study POC
Agreement Number:
1023443
Agreement Value:
$75,000.00
Agreement Date:
Nov 1, 2024 - Feb 21, 2025
Description:
As part of Multinational Corporate Collaboration Program, the project “IAVI Elarex VSV Stability Study POC” will focus on proving that the Elarex formulation and process to stabilize a VSV vectored vaccine, is effective when used with IAVI's Marburg virus vaccine.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Burlington, Ontario, CA L7L 4X5
Reference Number:
172-2024-2025-Q3-1023443
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
756228474
Recipient Type:
For-profit organization
Recipient's Operating Name:
Elarex
Recipient's Legal Name:
ELAREX INC.
Federal Riding Name:
Burlington
Federal Riding Number:
35015
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
54171